4.5 Article

Value profile for respiratory syncytial virus vaccines and monoclonal antibodies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study

Dana Danino et al.

Summary: During the COVID-19 pandemic in Israel, reductions in pneumococcal and pneumococcus-associated diseases were strongly associated with the disappearance of specific respiratory viruses, rather than reduced pneumococcal carriage and density.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Stakeholder Perceptions About Group B Streptococcus Disease and Potential for Maternal Vaccination in Low- and Middle-Income Countries

Carsten Mantel et al.

Summary: This study conducted a rapid literature appraisal and a multicountry survey to gather information on stakeholders' perceptions of the public health importance of GBS disease and vaccination. The findings will inform evidence-based decision making on GBS vaccination.

CLINICAL INFECTIOUS DISEASES (2022)

Review Immunology

Risk Factors for Poor Outcome or Death in Young Children With Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis

Ting Shi et al.

Summary: This study provides a comprehensive report on the association between various risk factors and poor outcome or death in young children with RSV-ALRTI. More research is needed to elucidate the risk factors associated with poor outcome or death using multivariable analysis.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

You Li et al.

Summary: Respiratory syncytial virus (RSV) plays a significant role in morbidity and mortality burden globally in children aged 0-60 months, especially during the first 6 months of life and in low-income and middle-income countries. Passive immunization programs targeting RSV could have a substantial effect on reducing disease burden.

LANCET (2022)

Article Medicine, General & Internal

Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy

Eric A. F. Simoes et al.

Summary: This study investigated the efficacy, immunogenicity, and safety of a bivalent RSVpreF vaccine in pregnant women and their infants. The results showed that the vaccine elicited a strong immune response and efficient transplacental transfer, without any evident safety concerns.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants

Laura L. Hammitt et al.

Summary: A single injection of nirsevimab administered before the RSV season protected healthy late-preterm and term infants from medically attended RSV-associated lower respiratory tract infection.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Multidisciplinary Sciences

Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus

Joseph A. Lewnard et al.

Summary: Reducing antimicrobial consumption is crucial to tackle antimicrobial resistance. Respiratory syncytial virus (RSV) is a major cause of infant infections, and vaccinating pregnant women against RSV can significantly decrease the prescription of antimicrobial drugs in infants during the first 3 months of their lives.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Medicine, General & Internal

Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study

Beate Schmoele-Thoma et al.

Summary: The RSVpreF vaccine demonstrated efficacy against symptomatic RSV infection and viral shedding, without any apparent safety concerns.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Immunology

Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life

Andrea G. Buchwald et al.

Summary: This study showed that maternally transferred RSV antibodies were associated with protection of infants against RSV illnesses, and RSV titers in cord blood could predict the risk of infection in infants.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants

Eric A. F. Simoes et al.

Summary: The study indicates that suptavumab did not reduce the overall rate of childhood RSV respiratory infections due to a newly circulating mutant strain of RSV B. Genetic variation in circulating RSV strains will continue to pose challenges to prevention efforts.

CLINICAL INFECTIOUS DISEASES (2021)

Article Microbiology

Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study

David E. Tabor et al.

Summary: Respiratory syncytial virus (RSV) exhibits global molecular epidemiology among children, with RSV B predominating over RSV A globally and in most countries. Most RSV strains are from infants under 1 year of age, with a high proportion of male patients and no differences in subtype distribution.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Critical Care Medicine

National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study

You Li et al.

Summary: This study provides robust estimates of national burden of RSV-associated ALRI hospitalisation in children younger than 5 years by synthesizing data from various sources. The majority of RSV-associated ALRI hospitalisations occur in infants aged younger than 1 year. The estimates by rate-based and proportion-based methods generally agree, with exceptions in India, Kenya, Norway, and Philippines.

LANCET RESPIRATORY MEDICINE (2021)

Article Multidisciplinary Sciences

Respiratory syncytial virus B sequence analysis reveals a novel early genotype

Juan C. Munoz-Escalante et al.

Summary: RSV-B virus has multiple genotypes, but the lack of genotype assignation criteria has direct implications on viral evolution, viral detection methods, and vaccine design. This study classified the previously described 37 genotypes of RSV-B into fifteen distinct genotypes, and identified a new early circulating genotype GB0.

SCIENTIFIC REPORTS (2021)

Article Infectious Diseases

Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in US adults, 2015-2017

Jenna E. Holmen et al.

Summary: RSV-associated hospitalization is positively correlated with poverty and crowding at CT level. The incidence rate of RSV-associated hospitalization is higher in CTs with higher poverty and crowding levels. However, CT level poverty and crowding are not correlated with ICU admission or death rates.

BMC INFECTIOUS DISEASES (2021)

Editorial Material Infectious Diseases

Implementation strategies for passive respiratory syncytial virus immunisation

Charles J. Sande

LANCET INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study

You Li et al.

Summary: In LMICs with clear RSV seasonality, seasonal approaches to monoclonal antibody and maternal vaccine administration may optimize disease prevention by dose given compared with year-round administration.

LANCET INFECTIOUS DISEASES (2021)

Article Immunology

Socioeconomic costs of children <5 years hospitalised with acute respiratory infections in Kuala Lumpur, Malaysia

I-Ching Sam et al.

Summary: A study found that the economic costs of acute respiratory infections in children under 5 years old are high, with government subsidies covering the majority of the actual costs. Younger age, comorbidities, prematurity, and detection of respiratory viruses lead to increased costs.

VACCINE (2021)

Article Medicine, General & Internal

Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model

Ranju Baral et al.

Summary: This study evaluates the potential impact and cost-effectiveness of two interventions to prevent childhood RSV - a maternal vaccine and a monoclonal antibody (mAb). The research found that mAbs, with assumed higher efficacy and duration of protection, are expected to be more cost-effective than RSV maternal vaccines at similar prices.

BMJ OPEN (2021)

Article Immunology

Mortality From Respiratory Syncytial Virus in Children Under 2 Years of Age: A Prospective Community Cohort Study in Rural Maharashtra, India

Eric A. F. Simoes et al.

Summary: The study found that community deaths from respiratory syncytial virus (RSV) accounted for the majority of RSV lower respiratory tract infection deaths. Therefore, prevention efforts should be preferentially directed at populations where access to care is limited.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies

Padmini Srikantiah et al.

Summary: The Bill & Melinda Gates Foundation supported RSV mortality surveillance studies in low- and middle-income countries, revealing high mortality rates among infants and providing important information for the development of RSV immunization products.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Deaths Attributed to Respiratory Syncytial Virus in Young Children in High-Mortality Rate Settings: Report from Child Health and Mortality Prevention Surveillance (CHAMPS)

Dianna M. Blau et al.

Summary: The study findings suggest that respiratory syncytial virus (RSV) is an important cause of child deaths, particularly in young infants, in high-mortality rate settings in sub-Saharan Africa and south Asia. Besides RSV, birth defects and infections with other pathogens are common comorbid conditions contributing to child mortality.

CLINICAL INFECTIOUS DISEASES (2021)

Review Immunology

RSV neutralization assays - Use in immune response assessment

Rama Raghunandan et al.

Summary: RSV is a major cause of respiratory illness in children and infants worldwide, with no licensed vaccine available. Multiple RSV vaccine candidates are in clinical development, with a focus on inducing robust virus neutralizing immune responses through nAb-mediated interventions. Standardizing RSV neutralization assays is crucial for assessing nAb responses accurately and for comparing the immunogenicity of different vaccine candidates.

VACCINE (2021)

Article Immunology

Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions

Rachel S. Laufer et al.

Summary: The study estimated the cost-effectiveness of implementing respiratory syncytial virus preventive interventions in Mali, finding that long-acting monoclonal antibody at a price of $3 per dose is likely to be cost-effective from both government and donor perspectives.

VACCINE (2021)

Article Immunology

Cost-effectiveness of strategies for preventing paediatric lower respiratory infections associated with respiratory syncytial virus in eight Chinese cities

Di Liu et al.

Summary: This study evaluated the cost-effectiveness of maternal immunization, infant monoclonal antibody, and pediatric immunization in eight Chinese cities. Results suggest that seasonally timed administration may be more cost-effective than year-round administration.

VACCINE (2021)

Review Infectious Diseases

Mathematical modelling of respiratory syncytial virus (RSV) in low- and middle-income countries: A systematic review

Alex Mezei et al.

Summary: The review identified potential effectiveness of RSV vaccines and monoclonal antibodies from existing mathematical modelling literature in LMIC. Future models should take into account more factors for better assessment.

EPIDEMICS (2021)

Article Economics

Costs of Respiratory Syncytial Virus Hospitalizations in Colombia

Jefferson Antonio Buendia et al.

Summary: The study aimed to evaluate the medical costs associated with bronchiolitis hospitalizations caused by RSV infection among infants aged < 2 years in Colombia. It found that RSV infection places a high economic burden on the health system in Colombia, highlighting the need for cost-effectiveness models and RSV prevention strategies.

PHARMACOECONOMICS-OPEN (2021)

Article Allergy

Direct medical costs of RSV-related bronchiolitis hospitalizations in a middle-income tropical country

C. E. Rodriguez-Martinez et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2020)

Article Biotechnology & Applied Microbiology

Drivers and barriers of vaccine acceptance among pregnant women in Kenya

Nancy A. Otieno et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Article Medicine, General & Internal

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

S. A. Madhi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

M. Pamela Griffin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Geriatrics & Gerontology

The burden of respiratory infections among older adults in long-term care: a systematic review

Arielle Childs et al.

BMC GERIATRICS (2019)

Article Infectious Diseases

Inappropriate Antibiotic Prescribing for Acute Bronchiolitis in US Emergency Departments, 2007-2015

Jesse Papenburg et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2019)

Article Multidisciplinary Sciences

Respiratory syncytial virus A genotype classification based on systematic intergenotypic and intragenotypic sequence analysis

Juan Carlos Munoz-Escalante et al.

SCIENTIFIC REPORTS (2019)

Article Medicine, General & Internal

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection

Jeffrey C. Kwong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Immunology

Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children

Terho Heikkinen et al.

JOURNAL OF INFECTIOUS DISEASES (2017)

Editorial Material Immunology

Safety assessment of immunization in pregnancy

Sonali Kochhar et al.

VACCINE (2017)

Article Public, Environmental & Occupational Health

Respiratory syncytial virus outbreak on an adult stem cell transplant unit

Sean G. Kelly et al.

AMERICAN JOURNAL OF INFECTION CONTROL (2016)

Article Infectious Diseases

Local variations in the timing of RSV epidemics

Douglas B. Noveroske et al.

BMC INFECTIOUS DISEASES (2016)

Article Immunology

Advances in RSV vaccine research and development - A global agenda

Deborah Higgins et al.

VACCINE (2016)

Article Pediatrics

Preventing hospitalizations for respiratory syncytial virus infection

Joan L. Robinson et al.

PAEDIATRICS & CHILD HEALTH (2015)

Article Cell Biology

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera

Joan O. Ngwuta et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Immunology

The Source of Respiratory Syncytial Virus Infection In Infants: A Household Cohort Study In Rural Kenya

Patrick K. Munywoki et al.

JOURNAL OF INFECTIOUS DISEASES (2014)

Review Microbiology

Virus-induced exacerbations in asthma and CORD

Daisuke Kurai et al.

FRONTIERS IN MICROBIOLOGY (2013)

Review Medicine, Research & Experimental

Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis

Jessie R. Groothuis et al.

ADVANCES IN THERAPY (2011)

Article Immunology

Respiratory syncytial virus persistence in chronic obstructive pulmonary disease

Markus B. Sikkel et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)

Article Medicine, General & Internal

Respiratory syncytial virus infection in elderly and high-risk adults

AR Falsey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Public, Environmental & Occupational Health

RSV outbreak in a paediatric intensive care unit

K Thorburn et al.

JOURNAL OF HOSPITAL INFECTION (2004)